InvestorsHub Logo
Followers 158
Posts 10559
Boards Moderated 2
Alias Born 10/14/2001

Re: sam1933 post# 57190

Monday, 02/19/2007 12:20:27 AM

Monday, February 19, 2007 12:20:27 AM

Post# of 82595
DNAPrint genomics is in the forefront of this new diagnostic field, now referred to as pharmacogenomic profile diagnostics. The Company sees a substantial opportunity to commercialize pharmacogenomic classification products in partnership with pharmaceutical companies, leading to higher clinical success rates, fewer failed drugs, expanded patent protection and more focused cost-effective marketing.